Alexander Tchernev

I am currently pursuing a PhD at the University of Birmingham as part of the Midlands Integrative Biosciences Training Partnership (MIBTP).

My PhD project is focussed on the development and application of computational tools that utilise machine learning and artificial intelligence to better understand the process of cellular reprogramming. The ultimate goal is to determine how - and to what extent - the rejuvenation component of cellular reprogramming can be decoupled from the dedifferentiation component so that safer and more effective rejuvenation therapies can be developed.

Prior to my PhD project, I completed an integrated Master's degree in Biology at Merton College, University of Oxford, and was awarded a First Class (Distinction).

For my Master's project, I explored the effects of combinations of anti-aging interventions (caloric restriction, metformin, and nicotinamide mononucleotide (NMN)) on lifespan and healthspan in the nematode worm C. elegans.

My interests in the field of aging and longevity are broad, and I am also highly interested in the longevity biotech industry - especially in companies aiming to ultimately bring safe and effective cellular reprogramming and/or stem cell therapies to the clinic.

Do reach out via LinkedIn or email if you are involved in the longevity field or are supportive of our goal:

Longer - and Healthier - Life